Reading Room Production — page 135

ze We will be sure Please let me know if you have any questions. ) 1AM [AID DEA DART ID DIR-OCGR < IH/NIAID) [--] i >) E) >; P| >; Billet, ion A number of HHS OpDivs and offices, including any technical comments in the ng the bill on behalf of NIH. Please let me know if We have compiled the comments that meet NIH OLPA's request into the attached draft technical assistance document. Please note that NIH OLPA has requested examples, where possible. We have tried to add some examples to emphasize key points, but we welcome any suggestions and/or corrections as needed. We would appreciate your review and any edits by 10am Monday, July 15th. Given the quick turnaround, we are asking the Divisions to review concurrently with the NIAID OD. Please note that NIH OSP, NIH ORS/DOHS, and NIH OER will also be reviewing and providing comments. We will be sure to share with you any consolidated NIH comments that we receive. Thank you for your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Thursday, July 11, 2024 10:51 AM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Subject: URGENT ACTION by 12pm Friday 7/12: TA on Risky Research Review Act Importance: High Good morning, Background HHS has been asked by the Senate Homeland Security and Governmental Affairs Committee (Chair: Sen. Gary Peters, DMI; Ranking Member: Sen. Rand Paul, R-KY) to provide technical assistance (TA) on the attached draft legislation entitled the Risky Research Review Act. The draft bill would require the establishment of an independent life sciences research security board to review federal funding for certain proposed life sciences research as defined by the bill. NIAID is mentioned briefly on page 4 in a section describing limitations on membership of the board. HHS reports that the Committee intends to consider the bill on July 24. A number of HHS OpDivs and offices, including ASPR, CDC, and FDA, have been asked to review the bill along with NIH. Action Item By noon tomorrow, Friday July 12, please review the attached draft legislation and provide any technical comments in the attached HHS TA template. Please note that NIH ORS/DOHS and NIH OSP are also reviewing the bill on behalf of NIH. As you complete your review, please keep in mind the HHS guidance on technical assistance below. Please let me know if you have any questions. Thanks, Sara To ensure that the Department's comments are given full consideration, please observe the following guidelines in providing your office's comments: